PapersPMID:33460048
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“There is no clear evidence of an effect on anxiety (MD -0.20, 95% CI -4.84 to 4.44; 1 trial, 19 participants; change scores; Hamilton Anxiety Scale (HAM-A; scored from 0 to 56); very low-certainty evidence) or depression (MD 2.80, 95% CI -0.09 to 5.69; 1 trial, 19 participants; change scores; Hamilton Depression Scale (HAM-D; scored from 0 to 52); very low-certainty evidence) in analyses comparing IR methylphenidate with placebo.”
- Study
- RCT
- Participants
- 19
- Effect
- 2.8 mean difference, 95% CI −0.09 to 5.69
- Population
- adults with ADHD, immediate-release methylphenidate versus placebo; secondary outcome (depression)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with ADHD (outpatients, addiction-treatment inpatients, and an intensive outpatient programme for cocaine dependence); 10 RCTs, 497 participants
- Participants
- 497
- Comparator
- an active treatment / placebo
- Duration
- not reported
- Endpoints measured
- 9